Sodium 3-methyl-2-oxopentanoate

Catalog No.: 
ACMXCU423
CAS No.: 
3715-31-9
Molecular Formula: 
C6H9NaO3
Molecular Weight: 
152.13
Sodium 3-methyl-2-oxopentanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$91.00InquiryInquiry
1g98%$208.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium 3-methyl-2-oxopentanoate
IUPAC Namesodium 3-methyl-2-oxopentanoate
MDL No.MFCD00002584
Molecular FormulaC6H9NaO3
Molecular Weight152.13
SMILESCCC(C)C(C([O-])=O)=O.[Na+]
InChI KeySMDJDLCNOXJGKC-UHFFFAOYSA-M
SynonymKETOISOLEUCINE SODIUM SALT;DL-ALPHA-KETO-BETA-METHYL-N-VALERIC ACID SODIUM SALT;DL-ALPHA-KETO-BETA-METHYLVALERIC ACID SODIUM SALT;DL-3-METHYL-2-OXOPENTANOIC ACID SODIUM SALT;3-METHYL-2-OXOPENTANOIC ACID SODIUM SALT;(+/-)-3-METHYL-2-OXOVALERIC ACID SODIUM SALT;SODIUM ALPHA-KETO-BETA-METHYL-N-VALERATE;(+/-)-SODIUM 3-METHYL-2-OXOVALERATE
CAS No.3715-31-9
PubChem CID2724058

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMXCU423 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKVFM063 route compound structure diagram
    ACKVFM063488-15-3In Stock
  2. Then
  3. ACMXCU423 route product structure diagram
    ACMXCU4233715-31-9
Inquiry

2. ACMXCU423 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMXCU423 route product structure diagram
    ACMXCU4233715-31-9
Inquiry

3. ACMXCU423 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMXCU423 route product structure diagram
    ACMXCU4233715-31-9
Inquiry

Comments (0)